These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
527 related items for PubMed ID: 24635221
1. Combining multiple healthcare databases for postmarketing drug and vaccine safety surveillance: why and how? Trifirò G, Coloma PM, Rijnbeek PR, Romio S, Mosseveld B, Weibel D, Bonhoeffer J, Schuemie M, van der Lei J, Sturkenboom M. J Intern Med; 2014 Jun; 275(6):551-61. PubMed ID: 24635221 [Abstract] [Full Text] [Related]
2. Surveillance for safety after immunization: Vaccine Adverse Event Reporting System (VAERS)--United States, 1991-2001. Zhou W, Pool V, Iskander JK, English-Bullard R, Ball R, Wise RP, Haber P, Pless RP, Mootrey G, Ellenberg SS, Braun MM, Chen RT. MMWR Surveill Summ; 2003 Jan 24; 52(1):1-24. PubMed ID: 12825543 [Abstract] [Full Text] [Related]
3. The Food and Drug Administration's Post-Licensure Rapid Immunization Safety Monitoring program: strengthening the federal vaccine safety enterprise. Nguyen M, Ball R, Midthun K, Lieu TA. Pharmacoepidemiol Drug Saf; 2012 Jan 24; 21 Suppl 1():291-7. PubMed ID: 22262619 [Abstract] [Full Text] [Related]
4. EU-ADR healthcare database network vs. spontaneous reporting system database: preliminary comparison of signal detection. Trifirò G, Patadia V, Schuemie MJ, Coloma PM, Gini R, Herings R, Hippisley-Cox J, Mazzaglia G, Giaquinto C, Scotti L, Pedersen L, Avillach P, Sturkenboom MC, van der Lei J, Eu-Adr Group. Stud Health Technol Inform; 2011 Jan 24; 166():25-30. PubMed ID: 21685607 [Abstract] [Full Text] [Related]
9. Electronic healthcare databases for active drug safety surveillance: is there enough leverage? Coloma PM, Trifirò G, Schuemie MJ, Gini R, Herings R, Hippisley-Cox J, Mazzaglia G, Picelli G, Corrao G, Pedersen L, van der Lei J, Sturkenboom M, EU-ADR Consortium. Pharmacoepidemiol Drug Saf; 2012 Jun 24; 21(6):611-21. PubMed ID: 22315152 [Abstract] [Full Text] [Related]
10. Detection of adverse drug reaction signals using an electronic health records database: Comparison of the Laboratory Extreme Abnormality Ratio (CLEAR) algorithm. Yoon D, Park MY, Choi NK, Park BJ, Kim JH, Park RW. Clin Pharmacol Ther; 2012 Mar 24; 91(3):467-74. PubMed ID: 22237257 [Abstract] [Full Text] [Related]
14. The role of databases in drug postmarketing surveillance. Rodriguez EM, Staffa JA, Graham DJ. Pharmacoepidemiol Drug Saf; 2001 Mar 24; 10(5):407-10. PubMed ID: 11802586 [Abstract] [Full Text] [Related]
15. Data mining on electronic health record databases for signal detection in pharmacovigilance: which events to monitor? Trifirò G, Pariente A, Coloma PM, Kors JA, Polimeni G, Miremont-Salamé G, Catania MA, Salvo F, David A, Moore N, Caputi AP, Sturkenboom M, Molokhia M, Hippisley-Cox J, Acedo CD, van der Lei J, Fourrier-Reglat A, EU-ADR group. Pharmacoepidemiol Drug Saf; 2009 Dec 24; 18(12):1176-84. PubMed ID: 19757412 [Abstract] [Full Text] [Related]
17. The US Food and Drug Administration's Sentinel Initiative: expanding the horizons of medical product safety. Robb MA, Racoosin JA, Sherman RE, Gross TP, Ball R, Reichman ME, Midthun K, Woodcock J. Pharmacoepidemiol Drug Saf; 2012 Jan 24; 21 Suppl 1():9-11. PubMed ID: 22262587 [No Abstract] [Full Text] [Related]